Catalyst Wire Dossier Catalyst Wire Dossier

ADVM-043

· Adverum Biotechnologies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ADVM-043, covering 2022-08-08 to 2024-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-up Study of ADVM-043

See pricing